Antibody-oligonucleotide conjugates (AOCs) represent a rapidly expanding class of chimeric molecules that merge the precise target recognition of monoclonal antibodies with the functional, structural, or amplifiable properties of nucleic acids. By combining these two distinct biological macromolecules, researchers are unlocking unprecedented capabilities in both targeted therapeutics—such...
0 Commentarios
0 Veces compartido
134 Visualizaciones
0 Reseñas
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek